• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Takeover talk drives Hologic stock


Other headlinesSonoSite shows vascular products

Takeover talk drives Hologic stock
Wall Street is buzzing with rumors that Hologic is a takeover target. The rumors have helped drive share prices of the women’s health specialist from a year low of under $12 in early summer to nearly $18 this week. Best known in radiology circles for its digital mammography equipment, Hologic expanded into therapeutics and other women’s products two years ago through a merger with Cytec.  

SonoSite shows vascular products
The pioneer of handheld ultrasound is extending its reach in point-of-care medicine with technologies that address patient safety and mobile power for its vascular access ultrasound tools. Bothell, WA-based SonoSite showcased the enhancements at its booth Sept. 14 to 18 during the Association for Vascular Access (AVA) meeting in Las Vegas. Headlining the vascular exhibits are the company’s six-pound NanoMaxx, which is pending FDA clearance, a hand-carried unit that combines one-button operation with a fluid resistant touch screen user interface; LumenVu Catheter Guidance System, which is designed to visualize the placement of peripherally inserted central catheters at the point-of-care; and universal stands that charge  batteries onboard SonoSite’s M-Turbo, S Series, NanoMaxx and MicroMaxx product, when the hand-carried systems are docked to the stands.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Nina Kottler, MD, MS
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2024 MJH Life Sciences

All rights reserved.